Nuvectis Pharma Inc.

NVCT | NASDAQ

Price Alert Chart Builder DCF Calculator

$22.89

+$0.91 (+4.14%)

Sep 22, 2026, 12:02 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Net Income	-26.44M	-19M	-22.26M	-19.09M	-12.89M	-10K
Depreciation & Amortization	n/a	n/a	n/a	n/a	n/a	n/a
Stock-Based Compensation	6.03M	4.86M	4.71M	1.71M	1.89M	n/a
Other Working Capital	625K	2.17M	1.74M	1.97M	1.49M	10K
Other Non-Cash Items	n/a	n/a	n/a	n/a	n/a	n/a
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	4.4M	1.9M	1.6M	3.82M	1.49M	10K
Operating Cash Flow	-16.01M	-12.25M	-15.95M	-13.56M	-9.5M	n/a
Capital Expenditures	n/a	n/a	n/a	n/a	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	n/a	n/a	n/a	n/a	n/a	n/a
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-2.1M	-382K	9.8M	-4.07M	n/a	n/a
Financial Cash Flow	29.11M	11.65M	15.09M	27.81M	15.25M	n/a
Net Cash Flow	13.1M	-593K	-867K	14.25M	5.74M	n/a
Free Cash Flow	-16.01M	-12.25M	-15.95M	-13.56M	-9.5M	n/a
Adj. Free Cash Flow	-22.04M	-17.11M	-20.66M	-15.27M	-11.4M	n/a
Maintenance CapEx	n/a	n/a	n/a	n/a	n/a	n/a
Growth CapEx	n/a	n/a	n/a	n/a	n/a	n/a
Owner Earnings	-16.01M	-12.25M	-15.95M	-13.56M	-9.5M	n/a